Overview
Share price change
24h
Current
Min
0.98
Max
1.02
Income | 14M -6M |
|---|---|
Employees | 112 |
EBITDA | 3.3M -18M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +204.49% upside |
Next Earnings | 9 lis 2026 |
|---|
Market Cap | -4.3M 100M |
|---|---|
Previous open | 6.75 |
Previous close | 0.98 |
Inovio Pharmaceuticals Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
16 paź 2026, 23:52 UTC
Dell Technologies Inc shares are moving lower in after-market hours amid inflation concerns affecting tech valuations, despite being named a core AI partner for Honeywell.
Read
16 paź 2026, 23:51 UTC
Baker Hughes Co. has a market capitalization of approximately $54.96 billion, experiencing a modest increase in after-market trading following Friday's close.
Read
16 paź 2026, 23:46 UTC
Scholar Rock grants inducement equity awards for 61.02k shares to new employees as part of its strategy to attract talent for ISEMBLYD commercialization.
Read
16 paź 2026, 23:46 UTC
Apollo Commercial Real Estate Finance Inc. plans to voluntarily delist from the NYSE, with the last trading day expected on November 6, 2026.
Read
16 paź 2026, 23:41 UTC
General Electric Co shares are moving lower in after-market trading following a deal with CFM International for over 300 LEAP-1B engines for Turkish Airlines.
Read
16 paź 2026, 23:41 UTC
Boeing Co. secures an $80 million contract from the U.S. Navy for the MQ-25A Stingray unmanned aircraft system, expected to be completed by October 2031.
Read
16 paź 2026, 23:41 UTC
Tesla Inc shares are trading modestly lower in after-market hours, continuing a trend of decline and remaining significantly below their 20-day moving average.
Read
16 paź 2026, 23:36 UTC
Hingham Institution for Savings reports third-quarter net income of $12.67 million, a decline from $17.30 million year-over-year, with overall performance metrics indicating a decrease.
Read
16 paź 2026, 23:31 UTC
Celanese announces global price increases for LCP products, citing strong demand and rising costs, as shares decline in after-market trading.
Read
16 paź 2026, 23:31 UTC
Coinbase Global Inc shares are trading modestly lower in after-market hours, influenced by a decline in Bitcoin prices and broader market trends.
Read
16 paź 2026, 23:16 UTC
In after-market trading, Steel Dynamics Inc is rising, with analysts expecting earnings of approximately $5.40 per share on revenue of around $6.57 billion.
Read
16 paź 2026, 23:12 UTC
Morgan Stanley lowers Netflix's price target to $80 from $83, citing stagnant viewing hours and concerns over engagement trends ahead of earnings report.
Read
16 paź 2026, 23:11 UTC
Lyft Inc shares declined in after-market trading following the announcement of its new premium chauffeur brand, Alcove, amid broader market weakness.
Read
16 paź 2026, 23:11 UTC
RTX Corp's Raytheon business secured a $729 million contract for the Ku-band Radio Frequency Sensor and Coyote interceptor, boosting shares higher in after-market hours.
Read
16 paź 2026, 23:06 UTC
Gartner Inc shares traded lower in after-market hours, following a decline from Friday's close amid concerns over rising U.S. import and export prices.
Read
16 paź 2026, 23:06 UTC
Pomerantz LLP has initiated a class action lawsuit against FuelCell Energy Inc, alleging securities fraud and unlawful business practices involving the company and its officers.
Read
16 paź 2026, 23:06 UTC
UPS is trading slightly lower in after-market hours, following a brief high earlier in the session, amid ongoing service enhancements and cost management efforts.
Read
16 paź 2026, 23:02 UTC
Meta Platforms is set to report Q3 earnings on October 21, with analysts forecasting revenue of $63.31 billion and EPS of $5.60.
Read
16 paź 2026, 23:02 UTC
Bank of America Corp's Board has authorized cash dividends of $1.15K for Series F and G, and $0.27806 for Series E, payable in late 2026.
Read
16 paź 2026, 23:02 UTC
Shah Capital has withdrawn its registration as an investment adviser and reduced its stake in Novavax to 6.39%, selling 2.87 million shares at $11.35 each.
Read
16 paź 2026, 23:01 UTC
Citigroup maintains Neutral rating on Fiserv Inc and lowers its price target to $53 in a report published after market hours.
Read
16 paź 2026, 23:01 UTC
Citigroup reaffirms Buy rating on Walt Disney Co and raises price target to $140, indicating confidence in the company's future performance.
Read
16 paź 2026, 23:01 UTC
Viatris receives FDA approval for Ryzumvi to treat presbyopia in adults and seeks U.S. partners for commercialization under a licensing agreement with Opus Genetics.
Read
16 paź 2026, 23:01 UTC
Goldman Sachs Group Inc shares are trading modestly lower in after-market hours, retracing to their lowest point of the day and below the 20-day moving average.
Read
16 paź 2026, 23:01 UTC
Coca-Cola Co shares traded lower in after-market hours, despite KFC's upcoming switch to its beverages in U.S. restaurants starting January 2027.
Read
16 paź 2026, 22:51 UTC
Navigator Holdings Ltd shares declined in after-market hours, continuing a downward trend for six consecutive sessions amid broader market declines.
Read
16 paź 2026, 22:51 UTC
Power Integrations Inc granted 25.32k RSUs and 1.34k PSUs to 12 employees as a material inducement to employment, effective October 15, 2026.
Read
16 paź 2026, 22:21 UTC
Moody's Corp shares are trading modestly lower in after-market hours, continuing a decline from Friday's close.
Read
16 paź 2026, 20:31 UTC
Delek US Holdings, Inc. will hold a conference call on November 6, 2026, to discuss third-quarter results, with a press release before market open.
Read
16 paź 2026, 20:21 UTC
Ames National Corp reported Q3 EPS of $0.80, surpassing the $0.68 estimate, with sales increasing to $20.42 million from $16.58 million year-over-year.
Read
Peer Comparison
Price change
Inovio Pharmaceuticals Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 3.167 USD 204.49%
High 4 USD
Low 2.5 USD
Based on 3 Wall Street analysts offering 12 month price targets forInovio Pharmaceuticals Inc - Dist in the last 3 months.
Rating Consensus
By TipRanks
Buy
3 ratings
2
Buy
1
Hold
0
Sell
Based on 3 analysts giving stock ratings to Inovio Pharmaceuticals Inc - Dist in the past 3 months.
Financials
Selling and administration expenses
Pre-tax profit
Sales
Interest expense on debt
EBITDA
Operating profit
$